Connecticut Capital Management Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Connecticut Capital Management Group's AMGN Position: Q2 2026 in Review
Connecticut Capital Management Group reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $35.3K and leaving 744 shares worth $269K. The position accounts for 0.22% of the portfolio, ranked #99.
Connecticut Capital Management Group first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $298K in Q1 2026. 3,134 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Connecticut Capital Management Group held 744 shares of Amgen worth $269K as of Q2 2026.
- Connecticut Capital Management Group sold 103 Amgen shares in Q2 2026, an estimated $35.3K.
- Amgen made up 0.22% of Connecticut Capital Management Group's portfolio in Q2 2026, its #99 holding.
- Connecticut Capital Management Group first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
- Connecticut Capital Management Group's Amgen position peaked at $298K in Q1 2026.
- 3,134 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Connecticut Capital Management Group's 13F filing for Q2 2026, filed 20 Jul 2026.